Nichi-Iko's R&D expenditure FY 2013-2020

In fiscal year 2020, Nichi-Iko Pharmaceutical spent around 4.3 billion Japanese yen on R&D, up from approximately 3.5 billion yen in the previous fiscal year. Headquartered in Toyama Prefecture, Nichi-iko is a leading generic drug manufacturer in Japan in terms of sales.

Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

June 2020



Survey time period

fiscal year 2013 to 2020; the company's fiscal year starts on April 1 of the previous year and ends on March 31 of the stated year

Supplementary notes

Figures may differ from company data due to differences in rounding methods.
Figures prior to fiscal year 2017 are displayed according to J-GAAP. From fiscal 2017 onwards, the company has used IFRS.

1 Japanese yen equals 0.0093 U.S. dollars or 0.0083 euros as of June 2020.
Figures have been rounded.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Japan "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.